Endothelial cell markers are membrane-bound or cytoplasmic molecules expressed by
endothelial cells, which help their easier identification and discrimination from other cell …

Inhibition of tumor angiogenesis by blockading the vascular endothelial growth factor
(VEGF) signaling pathway is a promising therapeutic strategy for thyroid cancer. Lenvatinib …

Papillary thyroid carcinoma is the most common thyroid malignancy, and has an excellent
prognosis, even with cervical lymph node metastasis; however, histological variants are …

Background The incidence of papillary thyroid cancer (PTC) is markedly higher in women
than men during the reproductive years. In vitro studies have suggested that estrogen may …

Background Lenvatinib significantly prolonged progression-free survival (PFS) versus
placebo in the phase III Study of (E7080) LEnvatinib in differentiated Cancer of the Thyroid …

Currently, it is not entirely clear whether hypoxia-inducible factor-1α (HIF-1α) is involved in
the regulation of COX-2 expression and epithelial-to-mesenchymal transition (EMT), and …

Background This study aimed to investigate the expression of ZEB1 in osteosarcoma tissues
and to discuss the relationship between ZEB1 expression and osteosarcoma metastasis …

The aim of this study was to investigate the expression of ZEB1 in gastric carcinoma, its
correlation with the clinicopathology of gastric carcinoma, and the role of ZEB1 in invasion …

Aim: The aim of this study is to explore the relationship between the neutrophil-to-
lymphocyte ratio (NLR) and clinicopathological features in patients with papillary thyroid …

Abstract Cyclooxygenase-2 (COX-2) participates in cancer invasion and metastasis by
decreasing the expression of E-cadherin. However, the molecular mechanisms through …